Table 4 Linear regression analyses between changes in FLI, BAAT and WC with specific Lysophosphatidylcholine adjusted for the percentage of weight loss in addition to sex, age and dietary group

 Δ LPC14:0

4.61

0.070

0.545

< 0.001

  Weight loss (5%)

13.55

0.016

  Weight loss (10%)

30.8

< 0.001

 Δ LPC15:0

−1.02

0.859

0.510

< 0.001

  Weight loss (5%)

13.94

0.018

  Weight loss (10%)

31.51

< 0.001

 Δ LPC16:1

2.92

0.040

0.575

< 0.001

  Weight loss (5%)

12.77

0.018

  Weight loss (10%)

29.33

< 0.001

 Δ LPC18:4

10.41

0.048

0.570

< 0.001

  Weight loss (5%)

13.27

0.015

  Weight loss (10%)

29.67

< 0.001

 Δ LPC20:4

0.21

0.204

0.532

< 0.001

  Weight loss (5%)

13.49

0.018

  Weight loss (10%)

30.60

< 0.001

 Δ LPC14:0

0.28

0.024

0.250

0.014

  Weight loss (5%)

0.13

0.563

  Weight loss (10%)

0.47

0.053

 Δ LPC15:0

0.41

0.126

0.115

0.105

  Weight loss (5%)

0.11

0.0646

  Weight loss (10%)

0.38

0.144

 Δ LPC16:1

0.00

0.384

0.062

0.183

  Weight loss (5%)

0.08

0.740

  Weight loss (10%)

0.41

0.123

 Δ LPC18:4

0.23

0.380

0.069

0.182

  Weight loss (5%)

0.09

0.707

  Weight loss (10%)

0.42

0.116

 Δ LPC20:4

0.00

0.630

0.049

0.230

  Weight loss (5%)

0.09

0.703

  Weight loss (10%)

0.45

0.098

 Δ LPC14:0

0.24

0.759

0.276

0.008

  Weight loss (5%)

0.33

0.849

  Weight loss (10%)

5.49

0.004

 Δ LPC15:0

3.32

0.032

0.445

< 0.001

  Weight loss (5%)

−0.63

0.662

  Weight loss (10%)

4.31

0.006

 Δ LPC16:1

0.72

0.124

0.274

0.007

  Weight loss (5%)

0.29

0.864

  Weight loss (10%)

4.43

0.016

 Δ LPC18:4

2.63

0.130

0.272

0.007

  Weight loss (5%)

0.41

0.808

  Weight loss (10%)

4.52

0.014

 Δ LPC20:4

0.09

0.069

0.299

0.004

  Weight loss (5%)

0.62

0.713

  Weight loss (10%)

4.50

0.011